Synapse - Mark Robson

Search Within

Mark E Robson

Results (681)

The Genomics ADvISER: Development and usability testing of a decision aid for the selection of incidental sequencing results

Journal Article

Bombard, Y.; Clausen, M.; Mighton, C.; Carlsson, L.; Casalino, S.; Glogowski, E.; Schrader, K.; Evans, M.; Scheer, A.; Baxter, N.; more...
European Journal of Human Genetics (2018)

Fulltext@MSK | Save

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

Journal Article

Bao, T.; Seidman, A. D.; Piulson, L.; Vertosick, E.; Chen, X.; Vickers, A. J.; Blinder, V. S.; Zhi, W. I.; Li, Q.; Vahdat, L. T.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Development of a novel measure of advanced cancer patients' perceived utility of secondary germline findings

Meeting Abstract

Hamilton, J. G.; Garzon, M. G.; Westerman, J. S.; Cadet, K.; Hay, J. L.; Offit, K.; Robson, M. E.
Annals of Behavioral Medicine (2018)

Fulltext@MSK | Save

Breast cancer family history and contralateral breast cancer risk in young women: An update from the Women’s Environmental Cancer and Radiation Epidemiology study

Journal Article

Reiner, A. S.; Sisti, J.; John, E. M.; Lynch, C. F.; Brooks, J. D.; Mellemkjær, L.; Boice, J. D.; Knight, J. A.; Concannon, P.; Capanu, M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: Analyses in the CIMBA consortium

Meeting Abstract

Van den Broek, A.; Robson, M. E.; Vos, J.; Bernstein, J. L.; Offit, K.; Rookus, M. A.; Chenevix-Trench, G.; Easton, D. F.; Antoniou, A. C.; Schmidt, M. K.
European Journal of Cancer (2018)

Fulltext@MSK | Save

Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

Meeting Abstract

Senkus-Konefka, E.; Domchek, S. M.; Im, S. A.; Xu, B.; Armstrong, A.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Conte, P.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Journal Article

Rebbeck, T. R.; Friebel, T. M.; Friedman, E.; Hamann, U.; Huo, D.; Kwong, A.; Olah, E.; Olopade, O. I.; Solano, A. R.; Teo, S. H.; more...
Human Mutation (2018)

Fulltext@MSK | Save

Health-related quality of life during a phase 2 study of talazoparib in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO)

Meeting Abstract

Hurvitz, S. A.; Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Balmaña, J.; Fasching, P. A.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial

Meeting Abstract

Im, S. A.; Xu, B.; Li, W.; Robson, M.; Ouyang, Q.; Yeh, D. C.; Iwata, H.; Park, Y. H.; Sohn, J. H.; Tseng, L. M.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Tolerability of olaparib monotherapy versus chemotherapy in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD

Meeting Abstract

Domchek, S. M.; Robson, M.; Im, S. A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Conte, P.; more...
Cancer Research (2018)

Fulltext@MSK | Save